The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression

Hanqing Hong1,2, Hai Zhu1, Shujun Zhao1

  • 1Department of obstetrics and gynecology, The Third Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.

Cell Death & Disease
|December 14, 2019
PubMed

Insights

Circular RNAs (circRNAs) are key in cancer. This study found circCLK3 is highly expressed in cervical cancer, promoting tumor growth and metastasis by sponging miR-320a and upregulating FoxM1.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are emerging as critical regulators in various cancers, but their specific roles in cervical cancer remain largely unexplored.
  • Understanding the molecular mechanisms underlying cervical cancer progression is essential for developing effective diagnostic and therapeutic strategies.

Purpose of the Study:

  • To investigate the expression and function of circRNAs in cervical cancer.
  • To elucidate the role of circCLK3 in cervical cancer development, progression, and metastasis.
  • To clarify the molecular pathway involving circCLK3, miR-320a, and FoxM1 in cervical cancer.

Main Methods:

  • Differential expression analysis of circRNAs in cervical cancer tissues versus adjacent normal tissues.
  • In vitro and in vivo functional assays (cell proliferation, migration, invasion, tumorigenesis, metastasis) to assess circCLK3's role.
  • Molecular mechanism studies including pull-down, RNA immunoprecipitation (RIP), luciferase reporter, and rescue assays to determine interactions between circCLK3, miR-320a, and FoxM1.

Main Results:

  • circCLK3 expression was significantly elevated in cervical cancer tissues and correlated with tumor differentiation, FIGO stage, and stromal invasion depth.
  • Downregulation of circCLK3 inhibited cervical cancer cell growth and metastasis, while its upregulation promoted these processes both in vitro and in vivo.
  • circCLK3 directly sponges miR-320a, which in turn suppresses FoxM1 expression. circCLK3 promotes cervical cancer progression by inhibiting miR-320a and increasing FoxM1 levels.

Conclusions:

  • circCLK3 acts as an oncogenic circRNA in cervical cancer, promoting proliferation, migration, and invasion.
  • The circCLK3/miR-320a/FoxM1 axis represents a novel regulatory pathway in cervical cancer progression.
  • circCLK3 holds potential as a diagnostic biomarker and a therapeutic target for cervical cancer.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K